While HFimpEF is associated with a better prognosis compared to HFrEF, patients with HFimpEF still face an elevated risk of mortality and hospitalization, particularly if GDMT is discontinued
At the same time, many companies are positioning their assets within a broader cardiometabolic framework, targeting indications that extend beyond obesity to include type 2 diabetes, cardiovascular disease, chronic kidney disease, sleep apnea, and MASH
Mentioned in some GHK-Cu transcriptomic studies as one of the affected matrix components
Furthermore, one more study was conducted to explore the mechanisms involved in the cardioprotective effect of hexarelin
Hims & Hers' international expansion into Canada follows a rocky relationship with Novo Nordisk
From understanding your insurance plans formulary to dealing with prior authorizations and appeals, multiple hurdles can stand between you and the medication you need